Bartaula-Brevik, S.; Leitch, C.; Hernandez-Valladares, M.; Aasebø, E.; Berven, F.S.; Selheim, F.; Brenner, A.K.; Rye, K.P.; Hagen, M.; Reikvam, H.;
et al. Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. J. Clin. Med. 2023, 12, 5546.
https://doi.org/10.3390/jcm12175546
AMA Style
Bartaula-Brevik S, Leitch C, Hernandez-Valladares M, Aasebø E, Berven FS, Selheim F, Brenner AK, Rye KP, Hagen M, Reikvam H,
et al. Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. Journal of Clinical Medicine. 2023; 12(17):5546.
https://doi.org/10.3390/jcm12175546
Chicago/Turabian Style
Bartaula-Brevik, Sushma, Calum Leitch, Maria Hernandez-Valladares, Elise Aasebø, Frode S. Berven, Frode Selheim, Annette K. Brenner, Kristin Paulsen Rye, Marie Hagen, Håkon Reikvam,
and et al. 2023. "Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity" Journal of Clinical Medicine 12, no. 17: 5546.
https://doi.org/10.3390/jcm12175546
APA Style
Bartaula-Brevik, S., Leitch, C., Hernandez-Valladares, M., Aasebø, E., Berven, F. S., Selheim, F., Brenner, A. K., Rye, K. P., Hagen, M., Reikvam, H., McCormack, E., Bruserud, Ø., & Tvedt, T. H. A.
(2023). Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. Journal of Clinical Medicine, 12(17), 5546.
https://doi.org/10.3390/jcm12175546
